Maswali yanayounganishwa na mwongozo · Kati Kiwango

AI katika Maswali ya Usambazaji na Uthibitishaji wa Famasia

Kagua uwekaji otomatiki wa duka la dawa, uthibitishaji wa misimbopau, utendakazi wa matumizi ya dawa, usalama wa usambazaji na uangalizi wa mfamasia. Angalia chanzo na upeo.

Njia za mwongozo zinazohusianaAI Katika Usambazaji wa Famasia na Uthibitishaji
Swali 1 ya 8

According to FDA DSCSA guidance, what information is part of a drug-package product identifier?

Hakiki kila swali8 maswali

Majibu na maelezo huonekana unapojibu maswali.

  1. According to FDA DSCSA guidance, what information is part of a drug-package product identifier?
    • A standardized numeric identifier, serial number, lot number, and expiration date
    • Tablet color and shape only
    • A patient’s diagnosis and allergies
    • The prescribing pharmacist’s name only
  2. What did the cited MedGuard study evaluate in outpatient medication decision support?
    • A guarantee that no prescription could be wrong
    • Alert acceptance, wrong-drug errors, and look-alike/sound-alike alerts
    • The color recognition accuracy of tablet photos
    • A model’s ability to set pharmacy law
  3. What medication-related issues can computer-triggered decision support flag at prescribing?
    • Whether a pharmacy is open
    • Whether a tablet photo is attractive
    • Potential drug-drug interactions, drug-allergy problems, and dosing issues
    • Whether a patient prefers a brand name
  4. What did the cited prescription-extraction study process?
    • Scanned receipts from retail stores
    • X-ray images of pill bottles
    • Barcode scans from a warehouse
    • Unstructured medication information in clinical discharge summaries
  5. What does ASHP safe-use guidance address for automated dispensing cabinets?
    • Policies, procedures, and quality-assurance processes for safe use
    • A rule that all clinical review is automated
    • A guarantee that every cabinet override is safe
    • A single rule for every jurisdiction
  6. What is one mechanism that can contribute to alert fatigue?
    • A unique warning that appears only once
    • Repeated or low-value alerts can reduce attention to later warnings
    • A barcode that correctly matches the drug package
    • A missing user interface
  7. What did the cited barcode eMAR study find about medication-administration errors?
    • Every medication error was eliminated
    • Barcode use replaced clinical checks
    • Barcode use reduced errors in the studied setting but did not eliminate them
    • A barcode confirmed the prescribed dose was clinically appropriate
  8. What is one purpose of a serialized product identifier under DSCSA?
    • Diagnose a drug allergy
    • Determine whether a dose fits a patient
    • Confirm a drug interaction is harmless
    • Support tracing a covered drug package through the supply chain